ABOUT

Shining a Light on SBS-IF
- Brand / Visual Identity
- Designed Assets
- Theming Concept
(+ Alternative Concepts)

Background:
VectivBio lacks any online disease awareness of short bowel syndrome with intestinal failure (SBS-IF). They are due to launch apraglutide, an SBS drug in 2025. This campaign aims to highlight awareness of SBS amongst HCPs and patients before this drug launch, and want to hammer home how much SBS can affect a patient’s life.

The Audience:
Haematologists

SMIT:
Paving the way for better outcomes is SBS-IF

Objective:
To to raise awareness and build VectivBio’s reputation in this space ahead of launch